Analytical Data
-
Gene name
gp130/IL6ST
- Application
-
Alternative Names
CDw130; CD130; IL6ST; GP130-RAPS; IR6RB; IL6R-Beta; IR6RB; IR6-RB; Interleukin 6 Signal Transducer; Oncostatin M Receptor; Interleukin-6 Receptor Subunit Beta
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 97% as determined by SDS-PAGE.
-
Uniprot
P40189
-
Expression Region
Thr392~Thr505+Ala553~Leu566
-
Protein Length
Partial
-
Molecular Weight
21kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
gp130/IL6ST, known as glycoprotein 130, is a crucial signaling receptor component for the interleukin-6 (IL-6) cytokine family. This receptor plays a vital role in mediating immune responses, hematopoiesis, and inflammation. Abnormal signaling through gp130 has been implicated in various diseases, including autoimmune disorders and cancers, making it a significant target for therapeutic interventions. Researchers have been interested in the production of recombinant gp130/IL6ST proteins to study their structure, function, and potential as therapeutic agents. These recombinant proteins can help elucidate the mechanisms of IL-6 signaling pathways and facilitate the development of strategies to modulate these pathways in disease contexts. Additionally, gp130/IL6ST has applications in drug development, particularly in the design of monoclonal antibodies and other biologics aimed at blocking IL-6 signaling. By unraveling the intricate roles of gp130 in cellular communication, scientists aim to provide insights into potential biomarkers for disease prognosis and treatment responses, further highlighting the protein's importance in medical research.
